Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study-Reference-Cited by-同舟云学术

Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study

Published:2022-10-11 Issue:1 Volume:10 Page:322-333
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Zhou Hui‐min¹²,Zhan Rong‐jian³,Chen Xuanyu⁴,Lin Yi‐fen¹²,Zhang Shao‐zhao¹²^ORCID,Zheng Huigan⁴,Wang Xueqin⁵,Huang Meng‐ting¹²,Xu Chao‐guang¹²,Liao Xin‐xue¹²,Tian Ting⁴,Zhuang Xiao‐dong¹²

Affiliation:

1. Cardiology Department The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

2. NHC Key Laboratory of Assisted Circulation (Sun Yat‐Sen University) Guangzhou China

3. Zhongshan School of Medicine Sun Yat‐sen University Guangzhou China

4. School of Mathematics Sun Yat‐sen University Guangzhou China

5. School of Management University of Science and Technology of China Hefei China

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14068

Reference40 articles.

1. Heart Failure with Preserved Ejection Fraction

2. Research Priorities for Heart Failure With Preserved Ejection Fraction

3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

5. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment;Reviews in Cardiovascular Medicine;2024-06-25

2. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review;American Journal of Cardiovascular Drugs;2024-04-04

3. Spironolactone;Practical Diabetes;2024-02

4. Heterogeneous treatment effects of coronary artery bypass grafting in ischemic cardiomyopathy: A machine learning causal forest analysis;The Journal of Thoracic and Cardiovascular Surgery;2023-09